These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 19298496

  • 21. One-year treatment with rosuvastatin reduces intima-media thickness in 45 hypercholesterolemic subjects with asymptomatic carotid artery disease.
    Riccioni G, Vitulano N, Mancini B, Zanasi A, D'Orazio N.
    Pharmacology; 2010; 85(2):63-7. PubMed ID: 20110750
    [Abstract] [Full Text] [Related]

  • 22. METEOR Trial Reports on the Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis.
    Haddad RM, Ballantyne CM.
    Phys Sportsmed; 2010 Jun; 38(2):180-2. PubMed ID: 20631478
    [Abstract] [Full Text] [Related]

  • 23. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
    Tam LS, Li EK, Shang Q, Tomlinson B, Lee VW, Lee KK, Li M, Kuan WP, Li TK, Tseung L, Yip GW, Freedman B, Yu CM.
    Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
    [Abstract] [Full Text] [Related]

  • 24. Effects of rosuvastatin on vascular biomarkers and carotid atherosclerosis in lupus: a randomized, double-blind, placebo-controlled trial.
    Mok CC, Wong CK, To CH, Lai JP, Lam CS.
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):875-83. PubMed ID: 21309005
    [Abstract] [Full Text] [Related]

  • 25. Reduction of intima-media thickness in subjects with asymptomatic carotid disease: two cases from the Asymptomatic Carotid Atherosclerosis DIsease Manfredonia Study (ACADIM Study).
    Riccioni G, D'Orazio N.
    Clin Ter; 2007 Jun; 158(5):431-3. PubMed ID: 18062350
    [Abstract] [Full Text] [Related]

  • 26. Effect of number of ultrasound examinations on the assessment of carotid intima-media thickness changes over time: the example of the METEOR study.
    Peters SA, Palmer MK, Grobbee DE, Crouse JR, Evans GW, Raichlen JS, Bots ML, METEOR Study Group.
    J Hypertens; 2011 Jun; 29(6):1145-54. PubMed ID: 21546878
    [Abstract] [Full Text] [Related]

  • 27. The use of plaque score measurements to assess changes in atherosclerotic plaque burden induced by lipid-lowering therapy over time: the METEOR study.
    Peters SA, Dogan S, Meijer R, Palmer MK, Grobbee DE, Crouse JR, O'Leary DH, Evans GW, Raichlen JS, Bots ML.
    J Atheroscler Thromb; 2011 Jun; 18(9):784-95. PubMed ID: 21617330
    [Abstract] [Full Text] [Related]

  • 28. Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.
    Rollefstad S, Ikdahl E, Hisdal J, Olsen IC, Holme I, Hammer HB, Smerud KT, Kitas GD, Pedersen TR, Kvien TK, Semb AG.
    Arthritis Rheumatol; 2015 Jul; 67(7):1718-28. PubMed ID: 25778850
    [Abstract] [Full Text] [Related]

  • 29. Effect of rosuvastatin therapy on carotid plaque morphology and composition in moderately hypercholesterolemic patients: a high-resolution magnetic resonance imaging trial.
    Underhill HR, Yuan C, Zhao XQ, Kraiss LW, Parker DL, Saam T, Chu B, Takaya N, Liu F, Polissar NL, Neradilek B, Raichlen JS, Cain VA, Waterton JC, Hamar W, Hatsukami TS.
    Am Heart J; 2008 Mar; 155(3):584.e1-8. PubMed ID: 18294500
    [Abstract] [Full Text] [Related]

  • 30. Carotid intima-media thickness in children with familial hypercholesterolemia.
    Kusters DM, Wiegman A, Kastelein JJ, Hutten BA.
    Circ Res; 2014 Jan 17; 114(2):307-10. PubMed ID: 24192652
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Change in carotid intima-media thickness in a high-risk group of patients by intensive lipid-lowering therapy with rosuvastatin: subanalysis of the JART study.
    Yokoi H, Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yoshida M.
    Int Heart J; 2014 Jan 17; 55(2):146-52. PubMed ID: 24632963
    [Abstract] [Full Text] [Related]

  • 33. Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.
    Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT.
    Circulation; 1995 Oct 01; 92(7):1758-64. PubMed ID: 7671358
    [Abstract] [Full Text] [Related]

  • 34. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
    Ferdinand KC, Davidson MH, Kelly MT, Setze CM.
    Am J Cardiovasc Drugs; 2012 Apr 01; 12(2):117-25. PubMed ID: 22263674
    [Abstract] [Full Text] [Related]

  • 35. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L, Manfredi R, Colangeli V, Trapani FF, Salvadori C, Magistrelli E, Danese I, Verucchi G, Serra C, Viale P.
    AIDS Res Hum Retroviruses; 2013 Mar 01; 29(3):547-56. PubMed ID: 23098891
    [Abstract] [Full Text] [Related]

  • 36. Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study.
    Baldassarre D, Veglia F, Gobbi C, Gallus G, Ventura A, Crepaldi G, Fisicaro M, Rimondi S, Ricci G, Mancini M, Bong MG, Collatina S, Sirtori CR.
    Atherosclerosis; 2000 Aug 01; 151(2):575-83. PubMed ID: 10924737
    [Abstract] [Full Text] [Related]

  • 37. Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
    Kastelein JJ, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, Revkin JH, Grobbee DE, Riley WA, Shear CL, Duggan WT, Bots ML, RADIANCE 1 Investigators.
    N Engl J Med; 2007 Apr 19; 356(16):1620-30. PubMed ID: 17387131
    [Abstract] [Full Text] [Related]

  • 38. Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.
    Shukla A, Sharma MK, Jain A, Goel PK.
    Indian Heart J; 2005 Apr 19; 57(6):675-80. PubMed ID: 16521637
    [Abstract] [Full Text] [Related]

  • 39. Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
    Byington RP, Furberg CD, Crouse JR, Espeland MA, Bond MG.
    Am J Cardiol; 1995 Sep 28; 76(9):54C-59C. PubMed ID: 7572688
    [Abstract] [Full Text] [Related]

  • 40. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
    Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Alaupovic P, Kwong-Fu H, Azen SP.
    Ann Intern Med; 1996 Mar 15; 124(6):548-56. PubMed ID: 8597317
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.